Free Trial
NASDAQ:HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News

$27.98 -0.29 (-1.03%)
As of 06/20/2025 03:54 PM Eastern

About Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS)

Key Stats

Today's Range
$27.98
$28.37
50-Day Range
$26.75
$29.20
52-Week Range
$25.32
$36.03
Volume
3,247 shs
Average Volume
9,815 shs
Market Capitalization
$53.16 million
Assets Under Management
$50.25 million
Dividend Yield
1.64%
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Tema GLP-1, Obesity & Cardiometabolic ETF Expenses

TypeHRTSNASDAQ ETFsAll ETFs
Management Fee0.99%0.54%0.53%
Other Expenses0.00%0.52%0.56%
Total Expense0.99%0.74%0.73%
Fee Waiver-0.24%-0.50%-0.63%
Net Expense0.75%0.63%0.60%
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema GLP-1, Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter.

HRTS ETF News Headlines

HRT may help to protect the heart
Trump’s true trade war strategy
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
Oil Prices Spike Amid Middle East Tensions
Guardian Capital LP Launches Two New ETFs on CBOE Canada
See More Headlines

HRTS ETF - Frequently Asked Questions

Tema GLP-1, Obesity & Cardiometabolic ETF's stock was trading at $28.87 at the beginning of the year. Since then, HRTS stock has decreased by 3.1% and is now trading at $27.98.
View the best growth stocks for 2025 here
.

Top institutional investors of Tema GLP-1, Obesity & Cardiometabolic ETF include Sterling Investment Advisors Ltd. (9.40%) and Flow Traders U.S. LLC (2.97%).

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema GLP-1, Obesity & Cardiometabolic ETF investors own include Scilex (SCLX), Rigetti Computing (RGTI), Pfizer (PFE), BlackBerry (BB), Butterfly Network (BFLY), BioNTech (BNTX) and

Fund Details

Issuer
Tema Global
Fund Name
Tema GLP-1, Obesity & Cardiometabolic ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
93

Fund Statistics

Assets Under Management
$50.25 million
Average Daily Volume
$0.00
Discount/Premium
0.04%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
400 shs

Miscellaneous

Beta
0.93
Creation Unit
10,000
Creation Fee
$500.00
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Top 10 HRTS Holdings

HRTS Sector Exposure

HRTS Industry Exposure


This page (NASDAQ:HRTS) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners